Métabolisme et fonctions des acides gras oméga-3 à longue chaîne ...

Références Bibliographiques
Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS and Jebb
SA. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the
management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int. J.
Obes. (Lond). 2006, 30: 1535-1544.
Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Valle TT,
Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M
and Laakso M. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G)
genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish
Diabetes Prevention Study. Diabetes. 2003, 52: 1872-1876.
Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M, Kazdova L, Ogston N,
Baranowski M, Gorski J, Janovska P, Kus V, Polak J, Mohamed-Ali V, Burcelin R,
Cinti S, Bryhn M and Kopecky J. n-3 fatty acids and rosiglitazone improve insulin
sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a
high-fat diet. Diabetologia. 2009, 52: 941-951.
Kunesová M, Braunerová R, Hlavatý P, Tvrzická E, Stanková B, Skrha J, Hilgertová J,
Hill M, Kopecký J, Wagenknecht M, Hainer V, Matoulek M, Parízková J, Zák A and
Svacina S. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a
short-term weight reducing regimen on weight loss and serum fatty acid composition in
severely obese women. Physiol. Res. 2006, 55: 63-72.
Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY,
Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC and Stallings WC.
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Nature. 1996, 384: 644-648. Erratum in: Nature. 1997, 385:555
Lafontan M & Berlan M. Fat cell adrenergic receptors and the control of white and brown
fat cell function. J. Lip. Res. 1993, 34: 1057-1091.
Lafontan M & Berlan M. Fat cell a2-adenoceptors: the regulation of fat cell function and
lipolysis. Endocrine Rev. 1995, 16: 716-738.
Lago F, Dieguez C, Gómez-Reino J and Gualillo O. The emerging role of adipokines as
mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007, 18:
313-325.
Lake AC, Sun Y, Li JL, Kim JE, Johnson JW, Li D, Revett T, Shih HH, Liu W, Paulsen
JE and Gimeno RE. Expression, regulation, and triglyceride hydrolase activity of
Adiponutrin family members. J. Lipid Res. 2005, 46: 2477-2487.
144